Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Small molecule disruption of the LAG-3/HLA-II interaction: implications for modulating T-cell responses

Mason, Georgina 2019. Small molecule disruption of the LAG-3/HLA-II interaction: implications for modulating T-cell responses. PhD Thesis, Cardiff University.
Item availability restricted.

[thumbnail of 2019MasonG PhD.pdf] PDF - Accepted Post-Print Version
Restricted to Repository staff only until 19 July 2024 due to copyright restrictions.

Download (6MB)
[thumbnail of Cardiff University Electronic Publication Form] PDF (Cardiff University Electronic Publication Form) - Supplemental Material
Restricted to Repository staff only

Download (105kB)


Background Although recent advances in immunotherapy have given some remarkable results in patients with advanced cancers, they are only effective in a proportion of patients, and the search for more effective novel treatments is keenly pursued. Co-inhibitory receptor lymphocyte activation gene-3 (LAG-3) has been shown to inhibit immune responses and therefore, is an attractive target. Despite the importance of LAG-3 in multiple disease settings, including cancer, the role of LAG-3 is yet to be fully understood. However, it is possible that use of a LAG-3 inhibitor, in combination with other cancer therapies, will enhance the anti-tumour immune response. In this study, a novel screening strategy was developed and used to screen a small molecule library against LAG-3 binding to key ligand major histocompatibility complex (MHC)-II. Results AlphaScreen was developed as a screening strategy for weak protein/protein interactions (PPI). Initially the assay was developed using a model low affinity PPI: the T-cell receptor (TCR) binding to peptide-MHC targets. Having demonstrated the effectiveness of AlphaScreen for detecting very low affinity PPI, this approach was subsequently used to explore the biology of LAG-3/MHC-II interactions using a range of HLA (human leukocyte antigen)-DR and –DQ molecules. Following on from this, a high through-put small molecule library screen was employed to selectively inhibit LAG3 binding to HLA-II. From a library of 50 000 small molecules, 8 hit compounds were found. These compounds were tested in a cell toxicity assay, 6 of which were found to be nontoxic. Finally, to develop the whole cell assays further, substantial progress towards development of a LAG-3 reporter cell line was made, using a LAG-3-CD3ζ chimeric receptor in a NFAT reporter cell line. Conclusions The AlphaScreen assay was highly effective at interrogating low affinity PPI. This enabled LAG-3 binding to a range of HLA-II molecules to be examined and allowed identification of specific inhibitors of this interaction. These small molecules will be examined in the future to develop clinically relevant inhibitors.

Item Type: Thesis (PhD)
Date Type: Completion
Status: Unpublished
Schools: Medicine
Date of First Compliant Deposit: 20 December 2019
Last Modified: 21 May 2024 15:55

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics